 TUCSON, Ariz., July 23, 2021 GLOBE NEWSWIRE -- HTG Molecular Diagnostics, Inc. Nasdaq: HTGM HTG, a life science company whose mission is to advance precision medicine, today announced that, on July 13th and July 22nd, 2021 the Compensation Committee of the HTG Board of Directors granted inducement stock option awards to purchase an aggregate of 30,000 shares of common stock to two employees who have recently joined HTG. 